Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.71B | $3.14B | $3.72B | $4.48B | $4.36B | $5.71B | $6.22B | $7.12B | $8.35B | $10.1B |
| Revenue growth | — | 16.0% | 18.7% | 20.3% | -2.7% | 31.0% | 9.0% | 14.5% | 17.2% | 20.5% |
| Gross profit | $1.89B | $2.20B | $2.60B | $3.11B | $2.86B | $3.96B | $4.20B | $4.73B | $5.63B | $6.64B |
| Gross margin | 69.9% | 70.2% | 69.9% | 69.4% | 65.6% | 69.3% | 67.4% | 66.4% | 67.5% | 66.0% |
| Operating income | $950M | $1.06B | $1.20B | $1.37B | $1.05B | $1.82B | $1.58B | $1.77B | $2.35B | $2.95B |
| Operating margin | 35.1% | 33.9% | 32.2% | 30.7% | 24.1% | 31.9% | 25.3% | 24.8% | 28.1% | 29.3% |
| Net income | $738M | $671M | $1.13B | $1.38B | $1.06B | $1.70B | $1.32B | $1.80B | $2.32B | $2.86B |
| Net margin | 27.3% | 21.4% | 30.3% | 30.8% | 24.3% | 29.9% | 21.3% | 25.2% | 27.8% | 28.4% |
| EPS (diluted) | $6.26 | $5.77 | $9.49 | $3.85 | $2.94 | $4.66 | $3.65 | $5.03 | $6.42 | $7.87 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.09B | $1.14B | $1.17B | $1.60B | $1.48B | $2.09B | $1.49B | $1.81B | $2.42B | $3.03B |
| Capital expenditures | $53.9M | $191M | $187M | $426M | $342M | $340M | $532M | $1.06B | $1.11B | $540M |
| Free cash flow | $1.03B | $953M | $982M | $1.17B | $1.14B | $1.75B | $958M | $750M | $1.30B | $2.49B |
| Share buybacks | $42.5M | $2.27B | $0.00 | $270M | $134M | $0.00 | $2.61B | $416M | $0.00 | $2.30B |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.04B | $648M | $858M | $1.17B | $1.62B | $1.29B | $1.58B | $2.75B | $2.03B | $3.37B |
| Total assets | $6.49B | $5.78B | $7.85B | $9.73B | $11.2B | $13.6B | $13.0B | $15.4B | $18.7B | $20.5B |
| Total liabilities | $709M | $996M | $1.16B | $1.45B | $1.41B | $1.60B | $1.86B | $2.04B | $2.21B | $2.52B |
| Shareholders' equity | $5.78B | $4.78B | $6.68B | $8.26B | $9.73B | $11.9B | $11.0B | $13.3B | $16.4B | $17.8B |
| Retained earnings | $1.57B | $115M | $1.52B | $2.49B | $3.26B | $4.76B | $3.50B | $4.74B | $6.80B | $7.01B |
| Shares (wtd avg diluted) | 118M | 116M | 119M | 358M | 361M | 366M | 362M | 357M | 362M | 363M |
Every figure is extracted from INTUITIVE SURGICAL INC’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.